Stay updated on Omalizumab in CRSwNP: Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in CRSwNP: Clinical Trial page.

Latest updates to the Omalizumab in CRSwNP: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for a completed omalizumab preclinical study of chronic rhinosinusitis with nasal polyps, including its study plan, eligibility criteria, locations, and outcomes. It also provides investigator, publication, and record-history details.SummaryDifference41%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0; the study page remains inaccessible and displays a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check57 days agoChange DetectedThe study page for NCT04583501 now renders a 403 Forbidden error instead of displaying the study record. The page shows a basic error message along with the site header and footer.SummaryDifference16%

Stay in the know with updates to Omalizumab in CRSwNP: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in CRSwNP: Clinical Trial page.